Global Pharmaceutical Packaging Market
Tamanho do mercado em biliões de dólares
CAGR :
% 
 Período de previsão |
2024 –2031 |
 Tamanho do mercado (ano base ) | USD 111.52 Billion |
 Tamanho do mercado ( Ano de previsão) | USD 192.66 Billion |
 CAGR |
% |
| Principais participantes do mercado |
|
>Mercado global de embalagens farmacêuticas, por produto (embalagens primárias, embalagens secundárias e terciárias), materiais (plásticos e polímeros, papéis e cartões, vidro, metais e outros), modo de administração de medicamentos (embalagens de administração de medicamentos orais, embalagens de entrega de medicamentos parenterais, tópicos Embalagem para entrega de medicamentos, embalagem para entrega de medicamentos para inalação, embalagem para entrega de medicamentos nasais, embalagem para entrega de medicamentos oculares, embalagem para entrega de outros medicamentos), utilizador final (empresas de fabrico farmacêutico, empresas de embalagens por contrato, farmácias e outras) - Tendências e previsões do sector para 2031.
Análise e insights do mercado de embalagens farmacêuticas
A externalização dos serviços de embalagem por contrato tornou-se crucial para as empresas farmacêuticas, permitindo-lhes concentrar-se nas competências essenciais e, ao mesmo tempo, cumprir normas exigentes. A Prespack oferece parcerias multidimensionais, dispensando os fabricantes de medicamentos ou dispositivos médicos de muitos processos. Esta tendência reflete o crescente setor de outsourcing farmacêutico, contribuindo, em última análise, para a expansão do mercado de embalagens farmacêuticas.
A Data Bridge Market Research analisa que o mercado global de embalagens farmacêuticas deverá atingir os 192,66 mil milhões de dólares até 2031, face aos 111,52 mil milhões de dólares em 2023, crescendo a um CAGR de 7,2% no período previsto de 2024 a 2031 .
|
Métrica de reporte |
Detalhes |
|
Período de previsão |
2024 a 2031 |
|
Ano base |
2023 |
|
Anos históricos |
2022 (personalizável para 2016–2021) |
|
Unidades Quantitativas |
Receita em biliões de dólares |
|
Segmentos cobertos |
Produto (embalagem primária, embalagem secundária e terciária), material (plásticos e polímeros, papéis e cartões, vidro, metais e outros), modo de administração de medicamentos (embalagem para administração de medicamentos orais, embalagens para administração de medicamentos parenterais, embalagens para administração de medicamentos tópicos, medicamentos para inalação Embalagem de entrega, embalagem de entrega de medicamento nasal, embalagem de entrega de medicamento ocular, embalagem de entrega de outro medicamento), utilizador final (empresas de fabrico farmacêutico, empresas de embalagem contratada, farmácias e outros ) |
|
Países abrangidos |
EUA, Canadá, México, Alemanha, Reino Unido, França, Itália, Holanda, Espanha, Rússia, Suíça, Turquia, Bélgica, Resto da Europa, China, Japão, Índia, Coreia do Sul, Austrália, Singapura, Indonésia, Tailândia, Malásia , Filipinas , Resto da Ásia-Pacífico, Brasil, Argentina, Resto da América do Sul, África do Sul, Emirados Árabes Unidos, Arábia Saudita, Egito, Israel, Resto do Médio Oriente e África |
|
Participantes do mercado abrangidos |
WestRock Company, Amcor plc, BD, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., CCL Industries, Gerresheimer AG, Schott AG, UFlex Limited, SGD Pharma, EPL Limited, Drug Plastics Group, Comar, e Daikyo Seiko Co., Ltd., entre outros |
Definição de mercado
A embalagem farmacêutica envolve o processo de acondicionamento de medicamentos e outros produtos farmacêuticos em materiais de embalagem que garantam a sua proteção, identificação e divulgação de informação. Estes materiais incluem plásticos, vidro, alumínio , papel e cartão, cada um escolhido pelas suas propriedades e aplicações específicas. Estes materiais são cuidadosamente selecionados com base na sua compatibilidade com o produto farmacêutico, na sua capacidade de proteção contra fatores externos e nos requisitos regulamentares.
Dinâmica global do mercado de embalagens farmacêuticas
Esta secção trata da compreensão dos impulsionadores, oportunidades, restrições e desafios do mercado. Tudo isto é discutido em detalhe abaixo:
Motoristas
- Aumento da externalização farmacêutica
As empresas farmacêuticas estão cada vez mais a optar por externalizar os processos de fabrico para embaladores contratados especializados. Esta mudança estratégica permite que estas empresas se concentrem nas suas competências essenciais, como investigação, desenvolvimento e marketing, deixando as complexidades das embalagens para os especialistas. Os embaladores contratados oferecem uma gama de serviços, incluindo design de embalagens, seleção de materiais e garantia de conformidade com requisitos regulamentares rigorosos. Isto é particularmente vantajoso para as empresas farmacêuticas que procuram soluções de embalagem inovadoras e personalizadas para os seus produtos.
- Evolução do papel das embalagens farmacêuticas na diferenciação do mercado
As embalagens evoluíram para além do seu papel tradicional de conterem meramente produtos farmacêuticos; é hoje um elemento chave na diferenciação destes produtos no mercado. Esta mudança é impulsionada pela intensificação da concorrência na indústria farmacêutica, onde as empresas estão a aproveitar as embalagens como uma ferramenta para diferenciar os seus produtos dos concorrentes. A embalagem serve como uma plataforma visual e informativa que comunica detalhes vitais sobre o produto, incluindo a sua qualidade, segurança e eficácia. Além disso, a embalagem atua como meio de marketing, ajudando a atrair os consumidores e a influenciar as suas decisões de compra. Em resposta a esta tendência, tem-se registado um aumento de soluções de embalagens inovadoras. Por exemplo, as embalagens inteligentes incorporam características digitais como etiquetas RFID ou códigos QR, permitindo aos consumidores aceder a informações adicionais sobre o produto ou rastrear a autenticidade.
A utilização de materiais ecológicos nas embalagens está a ganhar força, reflectindo a crescente consciência ambiental dos consumidores. Estas abordagens inovadoras não só diferenciam os produtos, como também contribuem para práticas sustentáveis, melhorando ainda mais a reputação da marca.
O foco na diferenciação de produtos através de embalagens está a impulsionar avanços significativos na indústria de embalagens farmacêuticas, promovendo um ambiente de mercado propício à inovação e melhoria contínuas.
Oportunidade
- Inovações em embalagens inteligentes
As inovações em embalagens inteligentes, como as etiquetas sensíveis à temperatura e o rastreio RFID, estão a revolucionar o mercado global de embalagens farmacêuticas. Estes avanços oferecem uma infinidade de benefícios, começando por uma maior visibilidade em toda a cadeia de abastecimento. As etiquetas sensíveis à temperatura, por exemplo, proporcionam uma monitorização em tempo real, garantindo que os medicamentos são armazenados e transportados em condições ideais. Esta capacidade é particularmente crucial para os produtos farmacêuticos, uma vez que manter a temperatura certa é fundamental para preservar a sua eficácia e segurança. Além disso, o rastreio RFID permite que as empresas rastreiem unidades individuais de produtos, garantindo autenticidade e evitando adulterações. Este nível de rastreabilidade não só ajuda no cumprimento das normas regulamentares, como também aumenta a confiança do consumidor. Além disso, as embalagens inteligentes facilitam processos de recolha eficientes, uma vez que as empresas podem identificar e recuperar rapidamente os produtos afetados.
Restrição / Desafios
- Falsificação e segurança de produtos
A contrafacção no sector farmacêutico representa um desafio multifacetado, apesar dos avanços nas tecnologias de embalagem. A proliferação de medicamentos falsificados não só põe em perigo a saúde dos doentes, como também corrói a confiança nos produtos farmacêuticos e na indústria. Estas atividades ilícitas envolvem frequentemente táticas sofisticadas, incluindo a replicação de embalagens e rótulos para imitar produtos genuínos. À medida que os falsificadores evoluem continuamente os seus métodos para evitar a deteção, as empresas farmacêuticas devem permanecer vigilantes e adaptar as suas estratégias de embalagem para se manterem à frente destas ameaças. Esta batalha contínua contra os medicamentos falsificados sublinha a importância crítica de soluções de embalagem inovadoras e de esforços colaborativos dentro da indústria e dos organismos reguladores para garantir a segurança e a integridade dos produtos farmacêuticos.
- Restrições de custos para a implementação de tecnologias avançadas de embalagem
O desenvolvimento e a implementação de tecnologias avançadas de embalagens, tais como embalagens inteligentes e medidas anti-contrafacção, exigem frequentemente investimentos substanciais em investigação, desenvolvimento e infra-estruturas tecnológicas. Para empresas mais pequenas com recursos limitados, estes custos podem ser proibitivos, impedindo-as de adotar soluções de embalagem inovadoras. Como resultado, estas empresas podem estar em desvantagem em comparação com os concorrentes de maior dimensão que podem investir em tecnologias de embalagem avançadas. Esta restrição prejudica o crescimento global e o potencial de inovação do mercado de embalagens farmacêuticas, limitando a disponibilidade de soluções de embalagens avançadas e prejudicando potencialmente a competitividade do mercado.
Desenvolvimentos recentes
- Em setembro de 2023, a WestRock Company WRK e a Smurfit Kappa Group Plc SMFKY acordaram fundir e criar a Smurfit WestRock, que deverá ser uma das maiores empresas de papel e embalagens do mundo, com um valor de cerca de 20 mil milhões de dólares.
- Em julho de 2023, a Constantia Flexibles anunciou a sua mais recente solução de embalagem farmacêutica, a folha coldform REGULA CIRC, uma tecnologia de ponta que estabelece um novo padrão de sustentabilidade em embalagens blister. Concebido com a circularidade em mente, o REGULA CIRC cumpre os regulamentos e a legislação futura, oferecendo uma solução de barreira total que cumpre os mais elevados padrões de embalagens sustentáveis.
- Em junho de 2022, a Berlin Packaging, um dos maiores fornecedores mundiais de embalagens híbridas, anunciou a aquisição do Andler Packaging Group, um distribuidor de valor acrescentado de recipientes e tampas de plástico, vidro e metal.
- Em dezembro de 2021, a Comar, fornecedor líder de dispositivos e conjuntos médicos personalizados e soluções de embalagens especiais, anunciou hoje que adquiriu a Omega Packaging, fabricante de produtos moldados por injeção e sopro que serve os mercados farmacêutico, nutracêutico, nutrição desportiva e cuidados com a pele.
- Em abril de 2022, a Amcor, líder no design e produção de soluções de embalagens éticas, revelou recentemente a adição de um novo laminado High Shield, mais ecológico, à sua gama de embalagens farmacêuticas.
Âmbito global do mercado de embalagens farmacêuticas
O mercado global de embalagens farmacêuticas está segmentado em quatro segmentos notáveis com base no produto, material, modo de administração do medicamento e utilizador final. O crescimento entre segmentos ajuda-o a analisar os nichos de crescimento e as estratégias para abordar o mercado e determinar as suas principais áreas de aplicação e as diferenças nos seus mercados-alvo.
Produto
- Embalagem Primária
- Embalagem Secundária e Terciária
Com base no produto, o mercado está segmentado em embalagens primárias e embalagens secundárias e terciárias.
Material
- Plásticos e Polímeros
- Papel e cartões
- Copo
- Metais
- Outros
Com base no material, o mercado está segmentado em plásticos e polímeros, papel e cartão, vidro, metais, entre outros.
Modo de administração de medicamentos
- Embalagem para administração oral de medicamentos
- Embalagem para entrega de medicamentos parenterais
- Embalagem tópica para administração de medicamentos
- Embalagem para administração de medicamentos para inalação
- Embalagem para administração nasal de medicamentos
- Embalagem ocular para administração de medicamentos
- Outras embalagens para entrega de medicamentos
Com base no modo de administração de medicamentos, o mercado está segmentado em embalagens para entrega de medicamentos orais, embalagens para entrega de medicamentos parenterais, embalagens para entrega de medicamentos tópicos, embalagens para entrega de medicamentos para inalação, embalagens para entrega de medicamentos nasais, embalagens para entrega de medicamentos oculares e outras embalagens para entrega de medicamentos.
Utilizador final
- Empresas de fabrico farmacêutico
- Empresas de embalagens contratadas
- Farmácias
- Outros
Com base no utilizador final, o mercado está segmentado em empresas fabricantes farmacêuticas, empresas de embalagens por contrato, farmácias, entre outras.
Análise/perspetivas regionais do mercado global de embalagens farmacêuticas
O mercado global de embalagens farmacêuticas está categorizado em quatro segmentos notáveis com base no produto, material, modo de administração do medicamento e utilizador final.
Os países abrangidos neste relatório de mercado são os EUA, Canadá, México, Alemanha, Reino Unido, França, Itália, Países Baixos, Espanha, Rússia, Suíça, Turquia, Bélgica, resto da Europa, China, Japão, Índia, Coreia do Sul, Austrália , Singapura , Indonésia, Tailândia, Malásia, Filipinas, resto da Ásia-Pacífico, Brasil, Argentina, resto da América do Sul, África do Sul, Emirados Árabes Unidos, Arábia Saudita, Egito, Israel e resto do Médio Oriente e África.
Espera-se que a América do Norte domine o mercado global de embalagens farmacêuticas devido à sua avançada infraestrutura de cuidados de saúde, ao quadro regulamentar robusto e ao investimento significativo em investigação e desenvolvimento. Prevê-se que os EUA dominem a América do Norte devido à sua infra-estrutura avançada de cuidados de saúde, à grande indústria farmacêutica e à elevada procura de soluções de embalagens inovadoras. Prevê-se que a China domine a região Ásia-Pacífico devido à sua indústria farmacêutica em rápida expansão, à sua grande base de consumidores e ao aumento dos investimentos em infra-estruturas de saúde e tecnologias de embalagem. Prevê-se que a Alemanha domine a região da Europa devido ao seu robusto sector de produção farmacêutica, ao forte ambiente regulamentar e à ênfase em normas de embalagens de alta qualidade.
A secção de países do relatório também fornece fatores individuais que impactam o mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Dados como novas vendas, vendas de reposição, demografia do país, atos regulamentares e tarifas de importação e exportação são alguns dos principais indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à concorrência grande ou escassa de marcas locais e nacionais e o impacto dos canais de vendas, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.
Cenário competitivo e análise global da quota de mercado de embalagens farmacêuticas
O panorama competitivo do mercado global de embalagens farmacêuticas fornece detalhes dos concorrentes. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em I&D, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, aprovações de produtos, largura e amplitude do produto, domínio de aplicação e tipo de produto curva da linha de vida. Os dados fornecidos acima estão apenas relacionados com o foco da empresa no mercado.
Alguns dos principais players de mercado que operam no mercado são a WestRock Company, Amcor plc, BD, AptarGroup, Inc., West Pharmaceutical Services, Inc., Berry Global, Inc., CCL Industries, Gerresheimer AG, Schott AG, UFlex Limited, SGD Pharma, EPL Limited, Drug Plastics Group, Comar e Daikyo Seiko Co., Ltd., entre outros.
SKU-
Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo
- Painel interativo de análise de dados
- Painel de análise da empresa para oportunidades de elevado potencial de crescimento
- Acesso de analista de pesquisa para personalização e customização. consultas
- Análise da concorrência com painel interativo
- Últimas notícias, atualizações e atualizações Análise de tendências
- Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Índice
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL PHARMACEUTICALS PACKAGING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 GLOBAL PHARMACEUTICALS PACKAGING MARKET : REGULATIONS
5.1 REGULATION IN U.S.:
5.2 REGULATION IN CANADA:
5.3 REGULATION IN EUROPE
5.4 REGULATION IN U.K.:
5.5 REGULATION IN INDIA
5.6 REGULATION IN CHINA
5.7 REGULATION IN UNITED ARAB EMIRATES
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PHARMACEUTICAL OUTSOURCING
6.1.2 GROWING PHARMACEUTICAL INDUSTRY
6.1.3 INCREASING DEMAND FOR PATIENT-FRIENDLY PACKAGING
6.1.4 EVOLVING ROLE OF PHARMACEUTICAL PACKAGING IN MARKET DIFFERENTIATION
6.2 RESTRAINTS
6.2.1 COST CONSTRAINTS FOR IMPLEMENTING ADVANCED PACKAGING TECHNOLOGIES
6.2.2 ENVIRONMENTAL CONCERNS REGARDING THE DISPOSAL OF PLASTIC PACKAGING
6.2.3 IMPACT OF STRINGENT REGULATORY STANDARDS ON PHARMACEUTICAL PACKAGING
6.3 OPPORTUNITIES
6.3.1 INNOVATIONS IN SMART PACKAGING
6.3.2 INCREASING FOCUS ON SUSTAINABILITY
6.3.3 RISE OF E-COMMERCE IN THE PHARMACEUTICAL SECTOR
6.4 CHALLENGES
6.4.1 COUNTERFEITING AND PRODUCT SECURITY
6.4.2 SUPPLY CHAIN VULNERABILITIES
7 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT
7.1 OVERVIEW
7.2 PRIMARY PACKAGING
7.2.1 BOTTLES
7.2.2 BLISTER PACKS
7.2.3 PARENTERAL CONTAINERS
7.2.4 CAPS & CLOSURES
7.2.5 PREFILLABLE INHALERS
7.2.6 POUCHES
7.2.7 MEDICATION TUBES
7.2.8 OTHERS
7.2.8.1 SYRINGES
7.2.8.2 VIALS & AMPOULES
7.2.8.3 OTHERS
7.3 SECONDARY AND TERTIARY PACKAGING
7.3.1 PAPERBOARD BOXES
7.3.2 CARTONS
7.3.3 SHRINK WRAP
7.3.4 OTHERS
8 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL
8.1 OVERVIEW
8.2 PLASTICS & POLYMERS
8.3 PAPER AND PAPERBOARDS
8.4 GLASS
8.5 METALS
8.6 OTHERS
9 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE
9.1 OVERVIEW
9.2 ORAL DRUG DELIVERY PACKAGING
9.3 PARENTERAL DRUG DELIVERY PACKAGING
9.4 TOPICAL DRUG DELIVERY PACKAGING
9.5 INHALATION DRUG DELIVERY PACKAGING
9.6 NASAL DRUG DELIVERY PACKAGING
9.7 OCULAR DRUG DELIVERY PACKAGING
9.8 OTHER DRUGS DELIVERY PACKAGING
10 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMA MANUFACTURING COMPANIES
10.3 CONTRACT PACKAGING COMPANIES
10.4 PHARMACIES
10.5 OTHERS
11 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 U.S.
11.2.2 CANADA
11.2.3 MEXICO
11.3 EUROPE
11.3.1 GERMANY
11.3.2 U.K.
11.3.3 FRANCE
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 NETHERLANDS
11.3.7 BELGIUM
11.3.8 RUSSIA
11.3.9 TURKEY
11.3.10 SWITZERLAND
11.3.11 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 CHINA
11.4.2 JAPAN
11.4.3 INDIA
11.4.4 SOUTH KOREA
11.4.5 AUSTRALIA
11.4.6 SINGAPORE
11.4.7 INDONESIA
11.4.8 THAILAND
11.4.9 MALAYSIA
11.4.10 PHILIPPINES
11.4.11 REST OF ASIA-PACIFIC
11.5 SOUTH AMERICA
11.5.1 BRAZIL
11.5.2 ARGENTINA
11.5.3 REST OF SOUTH AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 SOUTH AFRICA
11.6.2 U.A.E.
11.6.3 SAUDI ARABIA
11.6.4 EGYPT
11.6.5 ISRAEL
11.6.6 REST OF MIDDLE EAST AND AFRICA
12 GLOBAL PHARMACEUTICAL PACKAGING MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: GLOBAL
12.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
12.3 COMPANY SHARE ANALYSIS: EUROPE
12.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
13 SWOT ANALYSIS
14 COMPANY PROFILE
14.1 WESTROCK COMPANY
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 AMCOR PLC
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENT
14.3 BD
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 APTARGROUP, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COMPANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 WEST PHARMACEUTICAL SERVICES, INC.
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COMPANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 BERRY GLOBAL INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 COMPANY SHARE ANALYSIS
14.6.4 PRODUCT PORTFOLIO
14.6.5 RECENT DEVELOPMENT
14.7 CCL INDUSTRIES
14.7.1 COMPANY SNAPSHOT
14.7.2 COMPANY SHARE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 GERRESHEIMER AG
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 COMPANY SHARE ANALYSIS
14.8.4 PRODUCT PORTFOLIO
14.8.5 RECENT DEVELOPMENT
14.9 COMAR, LLC
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 DAIKYO SEIKO LTD.
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
14.11 DRUG PLASTICS GROUP
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENT
14.12 EPL LIMITED
14.12.1 COMPANY SNAPSHOT
14.12.2 REVENUE ANALYSIS
14.12.3 PRODUCT PORTFOLIO
14.12.4 RECENT DEVELOPMENT
14.13 SCHOTT PHARMA AG & CO. KGAA
14.13.1 COMPANY SNAPSHOT
14.13.2 REVENUE ANALYSIS
14.13.3 PRODUCT PORTFOLIO
14.13.4 RECENT DEVELOPMENT
14.14 SGD PHARMA
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 UFLEX LIMITED
14.15.1 COMPANY SNAPSHOT
14.15.2 REVENUE ANALYSIS
14.15.3 PRODUCT PORTFOLIO
14.15.4 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
Lista de Tabela
TABLE 1 PHARMA SECTOR’S GROWTH AT CURRENT PRICES
TABLE 2 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 3 GLOBAL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 4 GLOBAL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 5 GLOBAL PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 6 GLOBAL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 7 GLOBAL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 8 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 9 GLOBAL PLASTICS & POLYMERS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 10 GLOBAL PAPER AND PAPERBOARDS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 11 GLOBAL GLASS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 12 GLOBAL METALS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 13 GLOBAL OTHERS IN PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 14 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 15 GLOBAL ORAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 16 GLOBAL PARENTERAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 17 GLOBAL TOPICAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 18 GLOBAL INHALATION DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 19 GLOBAL NASAL DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 20 GLOBAL OCULAR DRUG DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 21 GLOBAL OTHER DRUGS DELIVERY PACKAGING IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 22 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 23 GLOBAL PHARMA MANUFACTURING COMPANIES IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 24 GLOBAL CONTRACT PACKAGING COMPANIES IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 25 GLOBAL PHARMACIES IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 26 GLOBAL OTHERS IN PHARMACEUTICAL PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 27 GLOBAL PHARMACEUTICALS PACKAGING MARKET, BY REGION, 2022-2031 (USD MILLION)
TABLE 28 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 29 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 30 NORTH AMERICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 31 NORTH AMERICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 32 NORTH AMERICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 33 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 34 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 35 NORTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 36 U.S. PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 37 U.S. PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 38 U.S. PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 39 U.S. SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 40 U.S. PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 41 U.S. PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 42 U.S. PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 43 CANADA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 44 CANADA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 45 CANADA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 46 CANADA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 47 CANADA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 48 CANADA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 49 CANADA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 50 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 51 MEXICO PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 52 MEXICO PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 53 MEXICO SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 54 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 55 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 56 MEXICO PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 57 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 58 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 59 EUROPE PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 60 EUROPE PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 61 EUROPE SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 62 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 63 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 64 EUROPE PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 65 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 66 GERMANY PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 67 GERMANY PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 68 GERMANY SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 69 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 70 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 71 GERMANY PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 72 U.K. PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 73 U.K. PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 74 U.K. PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 75 U.K. SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 76 U.K. PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 77 U.K. PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 78 U.K. PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 79 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 80 FRANCE PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 81 FRANCE PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 82 FRANCE SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 83 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 84 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 85 FRANCE PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 86 ITALY PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 87 ITALY PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 88 ITALY PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 89 ITALY SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 90 ITALY PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 91 ITALY PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 92 ITALY PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 93 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 94 SPAIN PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 95 SPAIN PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 96 SPAIN SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 97 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 98 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 99 SPAIN PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 100 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 101 NETHERLANDS PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 102 NETHERLANDS PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 103 NETHERLANDS SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 104 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 105 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 106 NETHERLANDS PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 107 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 108 BELGIUM PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 109 BELGIUM PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 110 BELGIUM SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 111 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 112 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 113 BELGIUM PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 114 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 115 RUSSIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 116 RUSSIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 117 RUSSIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 118 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 119 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 120 RUSSIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 121 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 122 TURKEY PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 123 TURKEY PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 124 TURKEY SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 125 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 126 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 127 TURKEY PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 128 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 129 SWITZERLAND PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 130 SWITZERLAND PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 131 SWITZERLAND SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 132 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 133 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 134 SWITZERLAND PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 135 REST OF EUROPE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 136 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 137 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 138 ASIA-PACIFIC PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 139 ASIA-PACIFIC PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 140 ASIA-PACIFIC SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 141 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 142 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 143 ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 144 CHINA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 145 CHINA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 146 CHINA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 147 CHINA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 148 CHINA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 149 CHINA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 150 CHINA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 151 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 152 JAPAN PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 153 JAPAN PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 154 JAPAN SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 155 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 156 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 157 JAPAN PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 158 INDIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 159 INDIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 160 INDIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 161 INDIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 162 INDIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 163 INDIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 164 INDIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 165 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 166 SOUTH KOREA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 167 SOUTH KOREA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 168 SOUTH KOREA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 169 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 170 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 171 SOUTH KOREA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 172 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 173 AUSTRALIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 174 AUSTRALIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 175 AUSTRALIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 176 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 177 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 178 AUSTRALIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 179 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 180 SINGAPORE PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 181 SINGAPORE PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 182 SINGAPORE SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 183 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 184 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 185 SINGAPORE PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 186 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 187 INDONESIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 188 INDONESIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 189 INDONESIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 190 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 191 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 192 INDONESIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 193 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 194 THAILAND PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 195 THAILAND PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 196 THAILAND SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 197 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 198 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 199 THAILAND PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 200 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 201 MALAYSIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 202 MALAYSIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 203 MALAYSIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 204 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 205 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 206 MALAYSIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 207 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 208 PHILIPPINES PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 209 PHILIPPINES PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 210 PHILIPPINES SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 211 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 212 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 213 PHILIPPINES PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 214 REST OF ASIA-PACIFIC PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 215 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 216 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 217 SOUTH AMERICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 218 SOUTH AMERICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 219 SOUTH AMERICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 220 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 221 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 222 SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 223 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 224 BRAZIL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 225 BRAZIL PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 226 BRAZIL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 227 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 228 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 229 BRAZIL PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 230 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 231 ARGENTINA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 232 ARGENTINA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 233 ARGENTINA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 234 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 235 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 236 ARGENTINA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 237 REST OF SOUTH AMERICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 238 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY COUNTRY, 2022-2031 (USD MILLION)
TABLE 239 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 240 MIDDLE EAST AND AFRICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 241 MIDDLE EAST AND AFRICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 242 MIDDLE EAST AND AFRICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 243 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 244 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 245 MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 246 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 247 SOUTH AFRICA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 248 SOUTH AFRICA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 249 SOUTH AFRICA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 250 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 251 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 252 SOUTH AFRICA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 253 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 254 U.A.E. PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 255 U.A.E. PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 256 U.A.E. SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 257 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 258 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 259 U.A.E. PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 260 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 261 SAUDI ARABIA PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 262 SAUDI ARABIA PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 263 SAUDI ARABIA SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 264 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 265 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 266 SAUDI ARABIA PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 267 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 268 EGYPT PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 269 EGYPT PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 270 EGYPT SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 271 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 272 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 273 EGYPT PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 274 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 275 ISRAEL PRIMARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 276 ISRAEL PARENTERAL CONTAINERS IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 277 ISRAEL SECONDARY AND TERTIARY PACKAGING IN PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
TABLE 278 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY MATERIAL, 2022-2031 (USD MILLION)
TABLE 279 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY DRUG DELIVERY MODE, 2022-2031 (USD MILLION)
TABLE 280 ISRAEL PHARMACEUTICALS PACKAGING MARKET, BY END USER, 2022-2031 (USD MILLION)
TABLE 281 REST OF MIDDLE EAST AND AFRICA PHARMACEUTICALS PACKAGING MARKET, BY PRODUCT, 2022-2031 (USD MILLION)
Lista de Figura
FIGURE 1 GLOBAL PHARMACEUTICALS PACKAGING MARKET: SEGMENTATION
FIGURE 2 GLOBAL PHARMACEUTICALS PACKAGING MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL PHARMACEUTICALS PACKAGING MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL PHARMACEUTICALS PACKAGING MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL PHARMACEUTICALS PACKAGING MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL PHARMACEUTICALS PACKAGING MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL PHARMACEUTICALS PACKAGING MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL PHARMACEUTICALS PACKAGING MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL PHARMACEUTICALS PACKAGING MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL PHARMACEUTICALS PACKAGING MARKET: SEGMENTATION
FIGURE 11 GROWING PHARMACEUTICAL INDUSTRY IS DRIVING THE GROWTH OF THE GLOBAL PHARMACEUTICALS PACKAGING MARKET FROM 2024 TO 2031
FIGURE 12 THE PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PHARMACEUTICALS PACKAGING MARKET IN 2024 AND 2031
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PHARMACEUTICALS PACKAGING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 14 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR PHARMACEUTICALS PACKAGING MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF GLOBAL PHARMACEUTICALS PACKAGING MARKET
FIGURE 16 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, 2023
FIGURE 17 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, 2024-2031 (USD MILLION)
FIGURE 18 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, CAGR (2024-2031)
FIGURE 19 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 20 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, 2023
FIGURE 21 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, 2024-2031 (USD MILLION)
FIGURE 22 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, CAGR (2024-2031)
FIGURE 23 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY MATERIAL, LIFELINE CURVE
FIGURE 24 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, 2023
FIGURE 25 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, 2024-2031 (USD MILLION)
FIGURE 26 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, CAGR (2024-2031)
FIGURE 27 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY DRUG DELIVERY MODE, LIFELINE CURVE
FIGURE 28 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, 2023
FIGURE 29 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, 2024-2031 (USD MILLION)
FIGURE 30 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, CAGR (2024-2031)
FIGURE 31 GLOBAL PHARMACEUTICALS PACKAGING MARKET: BY END USER, LIFELINE CURVE
FIGURE 32 GLOBAL PHARMACEUTICAL PACKAGING MARKET: SNAPSHOT (2023)
FIGURE 33 GLOBAL PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
FIGURE 34 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
FIGURE 35 EUROPE PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
FIGURE 36 ASIA-PACIFIC PHARMACEUTICAL PACKAGING MARKET: COMPANY SHARE 2023 (%)
Metodologia de Investigação
A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.
A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.
Personalização disponível
A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.
